Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Targher

Showing results (1-10 of 637) with videos related to

Pageof 64
Sort By:
Hepatobiliary Surgery and Nutrition|May 2, 2020
Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?Giovanni Targher
Hepatology (Baltimore, Md.)|September 27, 2007
"Buffalo" hump in nonalcoholic fatty liver diseaseGiovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2005
Nonalcoholic fatty liver disease and atherosclerosisGiovanni Targher
Hepatology (Baltimore, Md.)|September 22, 2005
Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver diseaseGiovanni Targher
Clinical Chemistry and Laboratory Medicine|January 15, 2011
Relationship of hepatic steatosis and alanine aminotransferase with coronary calcificationGiovanni Targher
Clinical Chemistry and Laboratory Medicine|December 1, 2009
Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative reviewGiovanni Targher
The New England Journal of Medicine|October 6, 2016
Polycystic Ovary SyndromeGiovanni Targher
Journal of Hepatology|July 19, 2006
Visceral adipose tissue may mediate the link between non-alcoholic fatty liver disease and endocrine abnormalitiesGiovanni Targher
Alimentary Pharmacology & Therapeutics|September 5, 2020
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLDGiovanni Targher
Liver International : Official Journal of the International Association for the Study of the Liver|August 2, 2020
Concordance between MAFLD and NAFLD diagnostic criteria in 'real-world' dataGiovanni Targher
Pageof 64

Showing results (1-10 of 637) with videos related to

Sort By:
Pageof 64
Hepatobiliary Surgery and Nutrition|May 2, 2020
Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?Giovanni Targher
Hepatology (Baltimore, Md.)|September 27, 2007
"Buffalo" hump in nonalcoholic fatty liver diseaseGiovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2005
Nonalcoholic fatty liver disease and atherosclerosisGiovanni Targher
Hepatology (Baltimore, Md.)|September 22, 2005
Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver diseaseGiovanni Targher
Clinical Chemistry and Laboratory Medicine|January 15, 2011
Relationship of hepatic steatosis and alanine aminotransferase with coronary calcificationGiovanni Targher
Clinical Chemistry and Laboratory Medicine|December 1, 2009
Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative reviewGiovanni Targher
The New England Journal of Medicine|October 6, 2016
Polycystic Ovary SyndromeGiovanni Targher
Journal of Hepatology|July 19, 2006
Visceral adipose tissue may mediate the link between non-alcoholic fatty liver disease and endocrine abnormalitiesGiovanni Targher
Alimentary Pharmacology & Therapeutics|September 5, 2020
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLDGiovanni Targher
Liver International : Official Journal of the International Association for the Study of the Liver|August 2, 2020
Concordance between MAFLD and NAFLD diagnostic criteria in 'real-world' dataGiovanni Targher
Pageof 64